Nortriptyline

Quick links to important sections

Nortriptyline

Method of action: Antidepressant, Psychoanaleptics

Treatment option: Depression, Enuresis, Bed-Wetting

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nortriptyline

Property Description
Active Ingredient Nortriptyline Hydrochloride
Form Oral Capsule, Oral Solution
Pharmacological Class Tricyclic Antidepressant (TCA)
Common Use Mood Stabilization, Chronic Nerve Pain Relief
Origin Synthetic Organic Compound

Defining Nortriptyline: Identity, Class, and Composition

Nortriptyline is a synthetic, single-ingredient medication, administered as its active salt, Nortriptyline Hydrochloride (HCl). The drug is classified as a Tricyclic Antidepressant (TCA). Nortriptyline is chemically a secondary amine and a dibenzocycloheptene derivative, recognized as a second-generation TCA, and it functions as an active metabolite of the drug amitriptyline. Nortriptyline Hydrochloride is prepared for oral intake, primarily supplied as a prescription-only drug in the pharmaceutical preparations of a solid capsule and a liquid oral solution. The availability of the oral solution form is a differentiating feature that allows for flexible administration and precise dosage adjustments, particularly for patients requiring careful dose titration.


What is the General Therapeutic Purpose of Nortriptyline?

The general purpose of Nortriptyline is to help restore balance to key chemical messengers in the central nervous system, thereby stabilizing mood and altering pain perception. The drug functions primarily as a Monoamine Reuptake Inhibitor, which means it blocks the reabsorption of the neurotransmitters norepinephrine and, to a lesser extent, serotonin, thus increasing their availability in the synaptic cleft. This foundational pharmacological action is recognized for its therapeutic efficacy across two broad general areas: supporting emotional stability in individuals with mood disorders and interfering with the transmission of chronic, persistent pain signals, such as those associated with certain nerve conditions. The dual-role utility of Nortriptyline—modulating both pain and mood pathways—characterizes its position as a reliable treatment option.

What side effects are possible with Nortriptyline?

Possible Side Effects and Safety Information

The safety profile of Nortriptyline is formally categorized by regulatory authorities, grouping adverse reactions by their frequency and the System-Organ Class (SOC) affected.

Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Very Common (affecting 1 in 10 patients) in official documents, often include dry mouth, constipation, tremor, dizziness, and headache. Effects classified as Common (1 in 100 but <1 in 10 patients) may involve orthostatic hypotension and tachycardia.

Reactions listed as Rare include events such as convulsion, delirium, and bone marrow depression (e.g., agranulocytosis). Suicidal ideation and behavior are categorized as Not Known (cannot be estimated from available data) but are subject to prominent regulatory warnings.


Serious Adverse Reactions and Safety Considerations

Official labeling contains a Boxed Warning concerning the increased risk of suicidal thinking and behavior in children, adolescents, and young adults (up to age 24), particularly during treatment initiation or dose changes.

Serious, though rare, cardiovascular risks documented include myocardial infarction, stroke, and arrhythmia, and the drug may prolong cardiac conduction time. For this reason, it is contraindicated during the acute recovery period following a myocardial infarction.

Specific population-based safety considerations are noted for older adults, who are more susceptible to adverse reactions like confusion and postural hypotension. Caution is also advised for patients with pre-existing conditions such as cardiovascular disease and those with a history of seizures, due to the drug's potential to lower the convulsive threshold. The medication may also impair the mental and physical abilities required for tasks like driving or operating machinery.

Overdose and Emergency Response

Overdose and When to Seek Help

Nortriptyline overdose, typical of Tricyclic Antidepressants (TCAs), is documented in regulatory labeling as potentially fatal and requires immediate emergency action. The official profile highlights severe effects on two core physiological systems.

Clinical Manifestations and Severe Outcomes

Overdose manifestations are primarily categorized by the official labels as Cardiotoxicity and Central Nervous System (CNS) effects.

System Documented Manifestations
Cardiovascular Cardiac Dysrhythmias, Severe Hypotension, Shock, QRS Complex Widening, Cardiac Arrest
Neurological CNS Depression, Coma, Convulsions (Seizures), Hyperpyrexia, Hyperactive Reflexes

Other regulator-documented findings include Pulmonary Edema, Metabolic Acidosis, and pronounced Anticholinergic signs such as Dilated Pupils and Urine Retention. The labeling notes that children are particularly sensitive to cardiotoxicity and seizures.

Emergency Regulatory Actions

Regulatory documents mandate that immediate medical attention must be sought for all suspected cases of overdose. Hospital monitoring is required as soon as possible due to the potential for rapid and severe deterioration. Treatment is officially defined as symptomatic and supportive, as no specific antidote is known.

Initial procedural steps described in official prescribing information include Gastric lavage and the administration of Activated charcoal. Continuous observation, including extended ECG monitoring, is necessary to manage life-threatening complications.

Therapeutic Uses of Nortriptyline

What Nortriptyline Treats: Main Uses and Benefits

Nortriptyline is commonly used to help with the symptomatic relief of Major Depressive Disorder (MDD), supporting mental balance and helping patients manage persistent low mood and a general lack of pleasure. This application is relevant in conditions characterized by periods of heightened symptoms, assisting with maintaining functional stability.


Nortriptyline is generally applied across domains where additional symptomatic support is needed. These uses include managing chronic neuropathic pain, such as the distressing burning and shooting sensations linked to Diabetic Neuropathy and Postherpetic Neuralgia, as well as providing prophylactic support to help reduce the frequency of episodic symptoms like migraine headaches. The medication is considered relevant in supportive therapeutic strategies for managing nicotine dependence.

“It contributes to improved comfort during periods of heightened symptoms by easing the overall symptom load.”

Quick Fact: Supportive Management for Persistent Nerve Discomfort

Nortriptyline is generally used for managing persistent nerve-related discomfort that may create noticeable physiological strain. This is applied in clinical settings that involve chronic, non-inflammatory pain patterns, and provides supportive relief when symptoms related to physical discomfort become more noticeable.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Nortriptyline — Official Regulatory Information

Category Official Regulatory Statement
Populations for whom use is allowed Adults with Major Depressive Disorder (MDD).
Populations for whom use is not recommended Pediatric patients (under 18) due to unestablished safety and efficacy.
Populations for whom use is contraindicated Patients receiving or recently stopping a Monoamine Oxidase Inhibitor (MAOI) (within 14 days), patients in the acute recovery phase following a Myocardial Infarction (MI), and those with known hypersensitivity to the drug.
Age-related eligibility rules Pediatric use is not established. Older adults require lower than usual starting dosages and close monitoring.
Pregnancy and lactation eligibility status Safe use has not been established; potential benefits must outweigh the possible hazards.
Eligibility-related restrictions Use only under close supervision for patients with Cardiovascular Disease, Narrow Angle Glaucoma, or a history of Seizures.

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording/Status
Eligibility Severity Classification Contraindicated (Absolute Ban); Not Recommended (Age Group); Safety Not Established (Pregnancy/Pediatric).

Resulting Eligibility Structure

Official eligibility statements:

  • Nortriptyline is contraindicated in patients using a Monoamine Oxidase Inhibitor (MAOI) or in the acute recovery phase following a heart attack.
  • The medicine is not approved for use in pediatric patients (under 18) because safety and effectiveness have not been established.
  • Eligibility requires close supervision for patients with Cardiovascular Disease or a history of Seizures due to known risks.

Connection to the overall eligibility profile: The official regulatory profile strictly defines eligibility through absolute contraindications based on acute cardiac events and drug-interaction risks, which mandate exclusion. For most patients, use is established in adults but is not recommended for children. For older adults and patients with specific comorbidities like glaucoma or hepatic impairment, the regulatory label requires the medicine to be administered only under explicit cautionary conditions.

What should I know about interactions with other medicines?

The official regulatory profile for Nortriptyline’s interactions is structured by specific prohibitions and pharmacokinetic constraints on co-administration.

Contraindicated Combinations

Monoamine Oxidase Inhibitors (MAOIs), including Linezolid and Intravenous Methylene Blue, are formally documented as contraindicated for co-use due to the risk of severe Serotonin Syndrome. A mandatory 14-day separation period is required after discontinuing an MAOI before initiating Nortriptyline therapy.

Pharmacokinetic and Exposure Modification

The primary mechanism for metabolic interaction involves the inhibition of the Cytochrome P450 2D6 (CYP2D6) enzyme. Co-administration with CYP2D6 inhibitors, such as Cimetidine, Quinidine, Fluoxetine, or Paroxetine, can result in clinically significant increases in Nortriptyline plasma concentrations due to reduced clearance. This is a population-specific consideration for individuals classified as CYP2D6 poor metabolizers.

Pharmacodynamic and Substance Interactions

Additive pharmacodynamic effects occur with other serotonergic agents and CNS depressants, including alcohol, which can potentiate central nervous system effects. The herbal product St. John’s Wort is noted in official sources as increasing the risk of Serotonin Syndrome. Additionally, the drug may increase the pressor effect of sympathomimetic agents and is documented to block the antihypertensive action of adrenergic neuron-blocking medicines.

Mechanism of Action

How Nortriptyline Works


Modulating Neurotransmitter Homeostasis via Reuptake Inhibition

Nortriptyline primarily functions by inhibiting the reabsorption of the neurotransmitter norepinephrine ( NE) and, to a lesser extent, serotonin (5 -HT) into nerve cells by blocking their respective transporters ( NET and SERT). This action increases the concentration and dwelling time of these monoamines in the synaptic space, initiating a slow, adaptive neuroplastic change in postsynaptic receptor sensitivity that alters central nervous system signaling dynamics over time.


Dampening Nerve Excitability through Sodium Channel Blockade

A separate, direct mechanistic domain involves Nortriptyline's action as a blocker of voltage-gated sodium channels ( Nav) found in nerve membranes. This direct molecular interaction stabilizes the electrical properties of the nerve cell, raising the threshold for generating an electrical impulse. This physiological effect results in the dampening and suppression of aberrant or high-frequency electrical signal transmission along nerve pathways, particularly where neuronal excitability is high.


Off-Target Receptor Antagonism

Beyond its primary targets, Nortriptyline exhibits a non-selective binding profile, acting as an antagonist at Histamine H1 and Muscarinic Acetylcholine ( mACh) receptors. Antagonism at these secondary sites modulates both histaminergic activity and the autonomic nervous system's cholinergic tone.

Dosage and Administration Information

How to Use Nortriptyline: Official Administration Guidelines

Nortriptyline is administered exclusively by the oral route, available in both capsule (10 mg, 25 mg, 50 mg, 75 mg) and liquid oral solution forms. The medicine may be taken with or without food.

Dosing Patterns and Frequency

Official guidelines define the appropriate dosage based on the age group. The adult starting dose is typically 25 mg three or four times daily, or 25 mg to 100 mg as a single dose. The usual maintenance range for adults is 50 mg to 100 mg per day, with a maximum recommended dose of 150 mg daily. The total daily dose may be taken in divided portions or as a single administration; the single dose is often administered at bedtime.

Population-Specific Use

Administration patterns are modified for certain populations to ensure proper use. For both older adults and adolescents, treatment initiation is guided by lower dosage rules, typically starting at 30 mg to 50 mg per day, administered either once daily or in divided doses.

Procedural Instructions

The entire therapeutic course involves specific procedural steps. Any dose adjustments, including the transition to a maintenance dose, must be performed gradually. If using the liquid oral solution, it must be measured with a calibrated dosing device for accuracy. Nortriptyline is used for both short-term symptomatic control and as part of a long-term regimen. Discontinuation of the medicine must also follow a gradual dose reduction pattern. In the event of a missed dose, the general instruction is to take it as soon as it is remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research evidence / Overview of studies for Nortriptyline


Evidence for Use in Major Depressive Disorder (MDD)

Nortriptyline was evaluated in research exploring short-term symptom changes in Major Depressive Disorder (MDD), primarily involving Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time, monitoring outcomes related to systemic or functional imbalance. Research describes patterns observed in the studies related to symptom evolution over the short trial duration, typically 6 to 12 weeks, with findings indicating short-term changes. The consistency of the documented findings in available RCTs and reviews was observed to lead to this evidence base being generally assigned a High Evidence Level for short-term outcomes. However, long-term effects are not fully established, and the certainty remains low regarding sustained functional recovery.


Evidence for Use in Chronic Neuropathic Pain

Nortriptyline was evaluated in studies exploring chronic neuropathic pain conditions, such as Diabetic Neuropathy and Postherpetic Neuralgia. The research primarily examined short-term, double-blind RCTs. These trials focused on outcomes related to physical discomfort, monitoring changes in pain intensity and recording patient-reported outcomes describing perceived discomfort. Research describes the data show patterns related to pain score measurements when compared against other types of interventions or placebo. The overall research base is often classified as providing a Moderate Evidence Level in this research scenario. The follow-up durations were limited, and studies were characterized by sample sizes that were modest.


Areas of Research Uncertainty and Study Limitations

The regulatory research record highlights several areas where data remain uncertain or limited. Across multiple indications, Research highlights that the follow-up durations were limited, with most controlled trials focused solely on short-term symptom changes. As a result, the long-term effects are not fully established, especially regarding sustained outcomes. Furthermore, comparative evidence is lacking against all currently available treatment classes, and for some applications, subgroup findings are uncertain. Research highlights what is known—and what is still uncertain—emphasizing that study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Neuropathic pain in adults: pharmacological management in non-specialist settings - NICE guideline CG173 (Evidence base for chronic pain)

Frequently Asked Questions (FAQ)

Common questions about Nortriptyline (FAQ)

Q: How is Nortriptyline different from similar tricyclic drugs like Amitriptyline?

Official documents describe Nortriptyline as a secondary amine TCA. It is also known to be the active substance (metabolite) that is formed in the body after a person takes Amitriptyline (a tertiary amine TCA). This chemical distinction identifies Nortriptyline as an active compound separate from Amitriptyline.

Q: Is feeling dizzy or drowsy a normal side effect of Nortriptyline?

According to the official product information, both feeling dizzy and feeling sleepy or drowsy are listed as common side effects of this medication. These effects are typically reported in official product information.

Q: How long does it usually take before I can tell if Nortriptyline is working?

The initial physical absorption of the drug happens quickly; however, the full therapeutic benefit may take longer to develop. Official studies indicate that the full therapeutic response, which is a key part of the treatment goals, typically takes several weeks to become apparent, often requiring one to two months.

Q: Are there any foods or drinks that should be avoided while taking Nortriptyline?

Official regulatory warnings state that the consumption of alcohol should be avoided while taking this medicine, as it can intensify central nervous system effects like sedation. The herbal supplement St. John’s Wort should also be avoided due to the increased risk of serious side effects. Official information notes that smoking tobacco may reduce the drug’s overall effectiveness.

Q: What happens if you suddenly stop taking Nortriptyline?

Regulatory instructions specify that discontinuation of this medicine must follow a gradual dose reduction pattern. Abruptly stopping treatment after prolonged use may lead to physical discomfort, which can include symptoms such as nausea, headache, and a general feeling of illness (malaise).

Q: Does Nortriptyline commonly cause dry mouth or blurred vision?

Yes, official side effect data classify both dry mouth and blurred vision as common side effects of Nortriptyline. These effects are listed as common in official safety data.

Q: How does Nortriptyline compare to SSRIs?

Nortriptyline is categorized as a Tricyclic Antidepressant (TCA), which is a different drug class than the Selective Serotonin Reuptake Inhibitors (SSRIs). Regulatory documentation indicates that combining Nortriptyline with an SSRI presents an increased risk of Serotonin Syndrome.

Q: Is Nortriptyline ever used to help with sleep issues?

The official drug information lists drowsiness as a common side effect of the medicine. Due to this potential sedative property, the total daily dose is described in guidelines as an administration option at bedtime.

Q: Does Nortriptyline typically cause weight gain?

Yes, official product safety data includes both an increased appetite and weight gain among the common side effects of this medication.

Q: What conditions is Nortriptyline officially approved to treat?

Regulatory bodies, such as the FDA, have officially approved Nortriptyline for the relief of symptoms associated with depression. This is the medicine's documented primary approved indication.

Q: Is the brand name Pamelor the same medicine as Nortriptyline?

Yes, Pamelor is a registered brand name for the active ingredient Nortriptyline Hydrochloride. The active ingredient in both the brand name and generic versions is the same.

Q: Is there a generic version of Nortriptyline available?

Yes, the active ingredient Nortriptyline Hydrochloride is widely available as a generic prescription medication.

Q: Is Nortriptyline considered to be an addictive drug?

According to official regulatory documentation, Nortriptyline is not considered to be an addictive drug. While abruptly stopping treatment can cause physical symptoms, known as discontinuation syndrome, these effects are not indicative of drug-seeking or addiction.

Q: What kind of monitoring (like blood tests) is generally advised when starting Nortriptyline?

Official warnings indicate that patients with pre-existing cardiovascular conditions must be closely supervised while taking this medication. Furthermore, for those receiving daily dosages above 100 mg, regulatory guidance recommends monitoring the drug's concentration levels in the blood plasma.

Q: Does Nortriptyline interact with medication for diabetes?

Official side effect data indicates that Nortriptyline has been reported to cause changes in blood sugar levels, resulting in either high or low blood sugar. Official data reports that its use alongside existing diabetes medication must be managed under professional care due to this potential effect.

Q: What is the chemical difference between Nortriptyline and its main metabolite?

Nortriptyline is chemically a secondary amine TCA. In the body, it is broken down into a compound known as its main active metabolite, 10-hydroxynortriptyline. The formal chemical structures of both of these compounds are precisely documented in official regulatory materials.

Q: Does Nortriptyline cause any noticeable changes in appetite?

Official drug safety information lists changes in appetite as a potential side effect. Official safety data indicates that changes in appetite can include either an increase or a decrease.

Q: What does the research say about Nortriptyline's potential to help with anxiety?

Official labeling for antidepressant drugs lists anxiety and agitation as symptoms that have been reported in patients undergoing treatment. For this reason, official documentation emphasizes that close monitoring for new or worsening anxiety is required during therapy.

How should Nortriptyline be stored and disposed of?

Storage Conditions

Nortriptyline must be stored at Controlled Room Temperature, which is between 20^circ to 25 C (68^circ to 77 F). The medication must be protected from light, excess heat, and moisture to maintain its stability. It is required to keep this medicine in a tight container that has a child-resistant closure. The regulatory instruction is to keep this and all medications out of the reach of children.

Disposal Instructions

To dispose of unused or expired Nortriptyline, the official guidance directs individuals to ask a healthcare professional (such as a pharmacist or doctor) for the proper procedure. Disposal must be performed in compliance with local regulations, and the product should not be disposed of using wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nortriptyline found in:

A-Z Index: